MedPath
HSA Approval

LETERO (LETROZOLE) TABLETS 2.5 mg

SIN14717P

LETERO (LETROZOLE) TABLETS 2.5 mg

LETERO (LETROZOLE) TABLETS 2.5 mg

December 30, 2014

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence HolderMEDICELL PHARMACEUTICAL (S) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L02BG04

letrozole

Manufacturer Information

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Hetero Labs Limited

Active Ingredients

Letrozole

2.500 mg

Letrozole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LETERO (LETROZOLE) TABLETS 2.5 mg - HSA Approval | MedPath